Drug metabolism and drug interactions · 2000 · 224 citations · 102 references
MedicineCancer BiologyOncologyApoptosisCancer PharmacologyCarcinogenesisApoptosis In CancerApoptosis PharmacologyCancer ChemopreventionAnticancer ActivityDietary Cancer PreventionDietary ChemopreventionMechanisms Of Diet-induced CarcinogenesisPhytochemicals In Cancer PreventionPolyphenol Chemoprevention
This review summarises current knowledge on the various molecular chemopreventive or therapeutic mechanisms that may be involved when the administration of flavonoids or polyphenols prevented chemical carcinogenesis in animal models. These mechanisms can be subdivided into the following: 1) the molecular mechanisms involved in preventing carcinogen metabolic activation, 2) the molecular mechanisms for preventing tumour cell proliferation by inactivation or downregulation of prooxidant enzymes or signal transduction enzymes, 3) the molecular cell death mechanisms for the induction of tumour cell death (apoptosis) and the molecular mechanisms for the inhibition of isolated mitochondria functions. Many of the flavonoids and polyphenols found in diets, supplements or herbal medicine were also ranked using "accelerated cytotoxic mechanism screening" by a combinatorial approach utilising isolated rat hepatocytes. A strong correlation of an early collapse of the mitochondrial membrane potential and cell death was found for most of the cytotoxic polyphenols but did not occur with non-toxic polyphenols. This screening could prove useful for eliminating polyphenols that have the potential for adverse health effects and for selecting safe and effective polyphenolic candidates for further development as supplements for preventing cancer or cardiovascular disease. Safety concerns of flavonoid/polyphenol supplements are also reviewed.
102
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Meishiang Jang, Lining Cai, George Udeani et al. · Science · 1997 · 4.9K citations
Medicine, Oncology, Pharmacology +17
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Judit Markovits, Claude Linassier, Philippe Fossé et al. · PubMed · 1989 · 552 citations
Georgine Agullo, Laurence Gamet‐Payrastre, Stéphane Manenti et al. · Biochemical Pharmacology · 1997 · 536 citations